Circulating adiponectin is inversely associated with risk of thyroid cancer: in vivo and in vitro studies (Q34218247)

31 July 2017

Circulating adiponectin is inversely associated with risk of thyroid cancer: in vivo and in vitro studies (English)

1 reference

31 July 2017

1 reference

Kalliope N Diakopoulos

Kalliope N Diakopoulos

7

0 references

John P Chamberland

John P Chamberland

5

0 references

Konstantinos N. Aronis

Konstantinos N Aronis

Christos Socrates Mantzoros

3

0 references

12

Christos S Mantzoros

1 reference

31 July 2017

4

Hyun-Seuk Moon

1 reference

31 July 2017

10

Geetha Mylvaganam

1 reference

31 July 2017

Sofia Tseleni-Balafouta

11

Sofia Tseleni-Balafouta

1 reference

31 July 2017

Nicholas Mitsiades

1

1 reference

31 July 2017

Kalliopi Pazaitou-Panayiotou

2

1 reference

31 July 2017

Xiaowen Liu

6

1 reference

31 July 2017

Vasileios Kyttaris

8

1 reference

31 July 2017

Vasiliki Panagiotou

9

1 reference

31 July 2017

language of work or name

English

0 references

publication date

21 September 2011

1 reference

The Journal of Clinical Endocrinology and Metabolism

31 July 2017

1 reference

31 July 2017

96

1 reference

31 July 2017

12

1 reference

31 July 2017

E2023-8

1 reference

Adiponectin in insulin resistance: lessons from translational research

31 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3232611

Low circulating adiponectin and resistin, but not leptin, levels are associated with multiple myeloma risk: a case-control study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3232611

Circulating adiponectin and leptin in relation to myelodysplastic syndrome: a case-control study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3232611

Leptin and adiponectin interact in the regulation of prostate cancer cell growth via modulation of p53 and bcl-2 expression

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3232611

Adiponectin in relation to malignancies: a review of existing basic research and clinical evidence

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3232611

Growth-inhibitory effect of adiponectin via adiponectin receptor 1 on human breast cancer cells through inhibition of S-phase entry without inducing apoptosis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3232611

Low adiponectin levels are associated with renal cell carcinoma: a case-control study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3232611

Total and high-molecular-weight adiponectin in breast cancer: in vitro and in vivo studies

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3232611

Adiponectin mediates antiproliferative and apoptotic responses in human MCF7 breast cancer cells

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3232611

Adiponectin as a growth inhibitor in prostate cancer cells

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3232611

Low plasma adiponectin levels and risk of colorectal cancer in men: a prospective study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3232611

Adiponectin and adiponectin receptors

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3232611

Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3232611

Adiponectin and breast cancer risk

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3232611

Plasma adiponectin concentrations in relation to endometrial cancer: a case-control study in Greece

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3232611

Serum triglycerides and cancer risk in the metabolic syndrome and cancer (Me-Can) collaborative study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3232611

Effect of adiponectin and sex steroid hormones on bone mineral density and bone formation markers in postmenopausal women with subclinical hyperthyroidism

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3232611

Insulin resistance and lower plasma adiponectin increase malignancy risk in nondiabetic continuous ambulatory peritoneal dialysis patients.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3232611

Circulating adiponectin concentrations were related to free thyroxine levels in thyroid cancer patients after thyroid hormone withdrawal

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3232611

Increased prevalence of insulin resistance in patients with differentiated thyroid carcinoma

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3232611

Serum concentrations of adiponectin and resistin in hyperthyroid Graves' disease patients

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3232611

Plasma adiponectin and gastric cancer.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3232611

A population-based case-control study of thyroid cancer

28 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21937620

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Adiponectin and resistin are associated with risk for myelodysplastic syndrome, independently from the insulin-like growth factor-I (IGF-I) system

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21937620

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Serum adiponectin concentrations and tissue expression of adiponectin receptors are reduced in patients with prostate cancer: a case control study

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21937620

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1210/JC.2010-1908

1 reference

31 July 2017

1 reference

31 July 2017

1 reference